GSK, Perrigo and Teva recall products; GSK facility affected in China explosion;

> A GlaxoSmithKline ($GSK) plant was among the many facilities affected by an explosion in a chemical warehouse last week in China's Tianjin port. Story

> Perrigo recalls 158,268 tubes of mometasone furoate ointment. Recall

> GlaxoSmithKline has recalled 17,675 cases of its OTC Panadol acetaminophen that failed dissolution specifications. Recall

> Recro Pharma says the contract manufacturing business it bought from Alkermes ($ALKS) has helped its revenue picture. Release

> Bausch and Stroebel, a German maker of custom pharma packaging equipment, is building a new plant in Brandford, CT. Report

> Teva ($TEVA) has recalled 19,504 bottles of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate tablets after an unknown impurity was found during testing. Report

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.